Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer

NCT01831024 is registered in ClinicalTrials.gov with Target Health Inc. as lead sponsor.

NCT NCT01831024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01831024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer
Lead sponsor
Target Health Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2013
Completion date
December 31, 2020
Enrollment
110 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemotherapy adjuvant